Sruthi S Nair1, P N Sylaja2, Jeyaraj Pandian3, M V Padma Srivastava4, Dheeraj Khurana5, Subhash Kaul6, Deepti Arora3, P Sankara Sarma7, Himani Khatter3, Aneesh B Singhal8. 1. Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, India. 2. Department of Neurology, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Trivandrum, India. Electronic address: sylajapn@hotmail.com. 3. Department of Neurology, Christian Medical College and Hospital (CMC), Ludhiana, India. 4. Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. 5. Department of Neurology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. 6. Department of Neurology, Nizam's Institute of Medical Sciences (NIMS), Hyderabad, India. 7. Department of Biostatistics, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India. 8. Department of Neurology, Stroke Service, Massachusetts General Hospital, Boston, USA.
Abstract
INTRODUCTION: Posterior circulation strokes (PCS) have been less extensively studied than anterior circulation strokes (ACS), especially regarding revascularization therapies. We analyzed the differences in baseline stroke characteristics, revascularization therapy and 3-month outcomes between PCS and ACS in a large prospective multicentre Indian stroke registry. METHODS: Patients with acute ischemic stroke recruited in the Indo-US collaborative stroke project from January 2012 to August 2014 were classified into PCS and ACS based on imaging-confirmed infarct location. Demographics, stroke severity, risk factors, and mechanisms were compared. We further compared these parameters in the subgroups who received revascularization therapies (RT) and no revascularization therapies (NRT). The primary outcome was 3-month modified Rankin scale (mRS). RESULTS: Of 1889 patients (1270 males), 1478 (78.2%) had ACS and 411 (21.8%) PCS. The median NIHSS was lower in PCS (7 vs 11, p < 0.001). Diabetes mellitus and hypertension were more common in PCS and rheumatic heart disease in ACS. Small artery occlusion was higher in PCS (23.8% vs 12.9%, p < 0.001). Only 28 (6.8%) PCS received RT compared to 213 (14.4%) ACS. At 90 days, a good functional outcome (mRS 0-2) was more common in PCS (56.4% vs 45.9%, p < 0.001) in NRT group, while no significant difference was noted in RT group. Stroke territory was not an independent predictor of 3-month outcome in regression analysis. In-hospital mortality was not different between the groups. CONCLUSIONS: The 3-month functional outcome and in-hospital mortality were not different between ACS and PCS. Compared to ACS, PCS received revascularization therapies less often.
INTRODUCTION: Posterior circulation strokes (PCS) have been less extensively studied than anterior circulation strokes (ACS), especially regarding revascularization therapies. We analyzed the differences in baseline stroke characteristics, revascularization therapy and 3-month outcomes between PCS and ACS in a large prospective multicentre Indian stroke registry. METHODS: Patients with acute ischemic stroke recruited in the Indo-US collaborative stroke project from January 2012 to August 2014 were classified into PCS and ACS based on imaging-confirmed infarct location. Demographics, stroke severity, risk factors, and mechanisms were compared. We further compared these parameters in the subgroups who received revascularization therapies (RT) and no revascularization therapies (NRT). The primary outcome was 3-month modified Rankin scale (mRS). RESULTS: Of 1889 patients (1270 males), 1478 (78.2%) had ACS and 411 (21.8%) PCS. The median NIHSS was lower in PCS (7 vs 11, p < 0.001). Diabetes mellitus and hypertension were more common in PCS and rheumatic heart disease in ACS. Small artery occlusion was higher in PCS (23.8% vs 12.9%, p < 0.001). Only 28 (6.8%) PCS received RT compared to 213 (14.4%) ACS. At 90 days, a good functional outcome (mRS 0-2) was more common in PCS (56.4% vs 45.9%, p < 0.001) in NRT group, while no significant difference was noted in RT group. Stroke territory was not an independent predictor of 3-month outcome in regression analysis. In-hospital mortality was not different between the groups. CONCLUSIONS: The 3-month functional outcome and in-hospital mortality were not different between ACS and PCS. Compared to ACS, PCS received revascularization therapies less often.
Authors: Tomáš Dorňák; Michal Král; Martin Hazlinger; Roman Herzig; Tomáš Veverka; Stanislav Buřval; Daniel Šaňák; Jana Zapletalová; Kristýna Antalíková; Petr Kaňovský Journal: Int J Stroke Date: 2015-08-26 Impact factor: 5.266
Authors: K N Vemmos; C E Takis; K Georgilis; N A Zakopoulos; J P Lekakis; C M Papamichael; V P Zis; S Stamatelopoulos Journal: Cerebrovasc Dis Date: 2000 Mar-Apr Impact factor: 2.762
Authors: Gian Marco De Marchis; Adrian Kohler; Nora Renz; Marcel Arnold; Marie-Luise Mono; Simon Jung; Urs Fischer; Alexander I Karameshev; Caspar Brekenfeld; Jan Gralla; Gerhard Schroth; Heinrich P Mattle; Krassen Nedeltchev Journal: J Neurol Neurosurg Psychiatry Date: 2010-08-27 Impact factor: 10.154
Authors: Wade S Smith; Michael H Lev; Joey D English; Erica C Camargo; Maggie Chou; S Claiborne Johnston; Gilberto Gonzalez; Pamela W Schaefer; William P Dillon; Walter J Koroshetz; Karen L Furie Journal: Stroke Date: 2009-10-15 Impact factor: 7.914
Authors: Jorge Pagola; Marc Ribo; José Alvarez-Sabin; Marta Rubiera; Estevo Santamarina; Olga Maisterra; Raquel Delgado-Mederos; Gemma Ortega; Manuel Quintana; Carlos A Molina Journal: J Neuroimaging Date: 2011-04 Impact factor: 2.486
Authors: Peter Sommer; Leonhard Seyfang; Alexandra Posekany; Julia Ferrari; Wilfried Lang; Elisabeth Fertl; Wolfgang Serles; Thomas Töll; Stefan Kiechl; Stefan Greisenegger Journal: J Neurol Date: 2016-11-07 Impact factor: 4.849